In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Nuojing Technology, an innovative biotech firm leveraging advanced artificial intelligence to streamline the research, ...
Sir Keir Starmer’s decision to invite Sir Pascal Soriot, AstraZeneca’s chief executive, to Beijing at the beginning of the ...
The figure of 50 billion yuan is not merely a sales target, but the inevitable result of the full-process closed-loop capabilities that Ali Health has accumulated over a decade, coming to fruition ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the previously ...
All deal values reflect company disclosures. Where parties have not disclosed terms, they are reported as undisclosed. No ...
Some 1,000 patients with a specific form of advanced breast cancer in England can, at last, receive AstraZeneca and Daiichi ...
Nate Massari’s business development and commercialization expertise in Immunology & Inflammation (I&I), particularly in ulcerative ...
Big Pharma firms have cut license deals worth tens of billions of dollars for cancer drugs invented in China.
The ink was barely dry on the FDA approval letter for AstraZeneca’s Etcamah before the oral SERD suffered a key clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results